Narrated by Andrew Wakefield, this new video is titled: “’Isolated’ autism—Your Child?”
It can be found by searching for “Autism Media Channel on Vimeo.”
In the video, Wakefield explains that in 2001, CDC whistleblower William Thompson and colleagues found a second connection between the MMR vaccine and autism.
The first connection, now widely known, was among African-American male babies.
This second connection was discovered in young children, regardless of race, who had a) received the MMR vaccine on schedule, as recommended by the CDC, and b) had no other factors sometimes observed to accompany autism, such as cerebral palsy, mental retardation, and birth defects.
This subset of children was labeled “isolated autism.” They showed an increased risk for autism after receiving the MMR vaccine.
Wakefield states or implies that whistleblower Thompson participated in this fraud as well, along with at least one other CDC colleague, Dr. Colleen Boyle.
Boyle, according to Wakefield, made a handwritten notation, in 2001, ordering an arbitrary and unwarranted reshuffling in the age-group parameters of the children in the study, in an effort to conceal the increased risk of autism.
But, Wakefield states, her strategy failed to bury the MMR vaccine-connection, so in the end, all the data suggesting an increased autism risk in this group were simply deleted from the study.
In the video, Wakefield posts a page of statistics on which there is handwritten note. This is presumably Colleen’s note ordering a reshuffling of categories, to bury the vaccine-autism connection. (See the 2m44s mark in the video).
This page, if verified, would open up a new front in the exposure of vaccine-autism fraud at the CDC.
Collen Boyle is not only an author of studies; she is a high-ranking CDC executive, acquiring her position in 2001, the year in which the above-mentioned purported fraud took place.
As her bio on the CDC website states, in 2001, she was made associate director “for science and public health for the newly created National Center on Birth Defects and Developmental Disabilities (NCBDDD). In that role, she was responsible for developing and coordinating the science activities of the National Center. In September 2010, she became acting director of NCBDDD. In her acting capacity, Coleen led the finalization of the center’s five-year strategic plan.”
Did that plan include covering up the vaccine-autism connection?